Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
plasma
Biotech
CSL Behring unveils its largest R&D site, slated to open in 2022
After three years of construction, CSL Behring has unveiled its new R&D site in Marburg, Germany, slated to be the company's largest.
Max Bayer
Sep 14, 2022 10:45am
Plasma therapy backed by CSL, Takeda fails phase 3 COVID-19 test
Apr 5, 2021 7:55am
Grifols ponies up $80M for polyclonal antibody biotech GigaGen
Mar 10, 2021 9:50am
Vaccines aren't enough. We need more COVID-19 treatments
Jan 11, 2021 10:45am
Convalescent plasma fails phase 2 in moderate COVID-19 patients
Oct 23, 2020 8:25am
NIH kicks off phase 3 trial for remdesivir, plasma combo
Oct 8, 2020 8:32pm
